BGM
TNYA icon

Burkehill Global Management’s Tenaya Therapeutics TNYA Stock Holding History

Burkehill Global Management’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.38M Hold
2,000,000
– – 0.07% 145
2025
Q4 		$1.42M Buy
+2,000,000
New +$2.72M 0.09% 134

Other funds holding TNYA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Burkehill Global Management's TNYA Position: Q1 2026 in Review

Burkehill Global Management held its Tenaya Therapeutics (TNYA) position steady in Q1 2026 at 2,000,000 shares worth $1.38M. The position accounts for 0.07% of the portfolio, ranked #145.

Burkehill Global Management first reported a position in TNYA in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.42M in Q4 2025. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

  • Burkehill Global Management held 2,000,000 shares of Tenaya Therapeutics worth $1.38M as of Q1 2026.
  • Burkehill Global Management left its Tenaya Therapeutics share count unchanged in Q1 2026.
  • Tenaya Therapeutics made up 0.07% of Burkehill Global Management's portfolio in Q1 2026, its #145 holding.
  • Burkehill Global Management first reported a position in Tenaya Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • Burkehill Global Management's Tenaya Therapeutics position peaked at $1.42M in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on Burkehill Global Management's 13F filing for Q1 2026, filed 15 May 2026.